This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments | MicrobiomeTrials
← Back to trials NCT06337032
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments Recruiting PHASE4 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-08-27Est. Completion: 2034-03
Enrollment target: 350 participantsLocations Helios Salud, Buenos Aires, Argentina Hospital del Niño, Panama City, Panama University of Stellenbosch, Cape Town, South Africa Enhancing Care Foundation, Durban, South Africa WITS RHI Research Centre, Johannesburg, South Africa Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa Be Part Yoluntu Centre, Paarl, South Africa The Aurun Institute, Pretoria, South Africa Perinatal HIV Research Unit, Soweto, South Africa Faculty of Medicine - Mahidol University, Bangkok Noi, Thailand Khon Kaen University, Khon Kaen, Thailand Joint Clinical Research Centre, Kampala, Uganda MU-JHU Research Collaboration/MU-JHU Care Ltd, Kampala, Uganda Baylor College of Medicine, Kampala, Uganda University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe Other microbiome trials you might be interested in HIV HIV -1 Infection
The goal of this study is to understand the profile of individuals who demonstrate transmitted drug resistance to Dolute…
Manaus, Brazil Completed Mar 8, 2024
HIV -1 Infection
Phase IV, multi-site, open-label, non-randomized study of the pharmacokinetics (PK) of long-acting injectable cabotegrav…
La Jolla, United States Est. completion Feb 15, 2028
Contact